Mette Kirstine Agger is a director of scPharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Lexeo Therapeutics, Inc.
6 Feb 24
3
Lexeo Therapeutics, Inc.
2 Nov 23
4
scPharmaceuticals Inc.
8 Jun 23
4
scPharmaceuticals Inc.
11 Jun 20
4
IMARA Inc.
16 Mar 20
3
IMARA Inc.
11 Mar 20
4
scPharmaceuticals Inc.
20 Jun 19
4
Trevi Therapeutics, Inc.
13 May 19
4
Trevi Therapeutics, Inc.
8 May 19
3
Trevi Therapeutics, Inc.
7 May 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Feb 24 | LXEO Lexeo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 17 | 36,000 | 612.00 k | 36,000 |
6 Jun 23 | SCPH scPharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 11.71 | 17,300 | 202.58 k | 17,300 |